Natural Product: NPC244335

Natural Product IDNPC244335
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
OVQSVMZESAVYPN-XYPWNMJBSA-N
IUPAC Name n.a.
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID 5316825
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000258] Steroids and steroid derivatives
        • [CHEMONTID:0003569] Pregnane steroids
          • [CHEMONTID:0001468] Gluco/mineralocorticoids, progestogins and derivatives

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey OVQSVMZESAVYPN-XYPWNMJBSA-N
Standard InCHI InChI=1S/C21H32O3/c1-12(22)17-11-18(24)19-15-5-4-13-10-14(23)6-8-20(13,2)16(15)7-9-21(17,19)3/h10,12,15-19,22,24H,4-9,11H2,1-3H3/t12-,15?,16?,17?,18?,19?,20-,21+/m0/s1
SMILES C[C@@H](C1CC(C2C3CCC4=CC(=O)CC[C@]4(C)C3CC[C@]12C)O)O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   332.24 Volume:   358.644
?
Van der Waals volume.
Dense:   0.926 LogP:   2.192
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   2.514
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -4.005
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   1.0 Rigid Bonds:   21.0
TPSA:   57.53
?
Topological Polar Surface Area.
H-Bond Acceptor:   3.0
H-Bond Donor:   2.0 Rings:   4.0
Heavy Atoms:   3.0

MedChem Properties

QED Drug-Likeness Score:   0.773 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   4.427 Fsp3:   0.857
MCE-18:   70.667
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Rejected GSK Rule:   Rejected
Golden Triangle Rule:   Rejected BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.409 Fluc inhibitor:   0.001
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.034
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.007
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.315 Promiscuous compounds:   0.185

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -4.767 MDCK Permeability:   -4.966
Pgp-inhibitor:   0.019 Pgp-substrate:   0.255
PAMPA:   0.889
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.004
20% Bioavailability (F20%):   0.442 30% Bioavailability (F30%):   0.196
50% Bioavailability (F50%):   0.924

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.781 MRP1:   0.974
Plasma Protein Binding (PPB):   79.936% Volume Distribution (VD):   -0.428
Fu: 17.262%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.521
OATP1B3 inhibitor:   0.761 BCRP inhibitor:   0.059
BSEP inhibitor:   0.842

ADMET: Metabolism

CYP1A2-inhibitor:   0.036 CYP1A2-substrate:   0.024
CYP2C19-inhibitor:   0.999 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.708 CYP2C9-substrate:   0.001
CYP2D6-inhibitor:   0.004 CYP2D6-substrate:   0.004
CYP3A4-inhibitor:   0.989 CYP3A4-substrate:   0.401
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.881
HLM stability:   0.958
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  15.956 Half-life (T1/2):  1.851

ADMET: Toxicity

hERG Blockers:  0.122 hERG Blockers (10um):  0.659
Human Hepatotoxicity (H-HT):  0.785 Drug-induced Liver Injury (DILI):  0.278
AMES Toxicity:  0.252 Rat Oral Acute Toxicity:  0.409
Maximum Recommended Daily Dose:  0.872 Skin Sensitization:  0.624
Carcinogencity:  0.915 Eye Corrosion:  0.01
Eye Irritation:  0.4 Respiratory Toxicity:  0.694
Drug-induced Neurotoxicity:  0.701 Ototoxicity:  0.561
Hematotoxicity:  0.073 Drug-induced Nephrotoxicity:  0.205
Genotoxicity:  0.387 RPMI-8226 Immunitoxicity:  0.062
A549 Cytotoxicity:  0.381 Hek293 Cytotoxicity:  0.695
BCF:   0.653
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.48
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   5.165
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.29
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO14263 Cipadessa baccifera Species Meliaceae Eukaryota leaves n.a. n.a. PMID[20666364]
NPO14263 Cipadessa baccifera Species Meliaceae Eukaryota n.a. n.a. n.a. PMID[32468815]
NPO14263 Cipadessa baccifera Species Meliaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO14263 Cipadessa baccifera Species Meliaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO14263 Cipadessa baccifera Species Meliaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO14263 Cipadessa baccifera Species Meliaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO14263 Cipadessa baccifera Species Meliaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC244335 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.7255 Intermediate Similarity NPC214043
0.7255 Intermediate Similarity NPC85774
0.6182 Remote Similarity NPC327115
0.6071 Remote Similarity NPC237712
0.6038 Remote Similarity NPC307176
0.6038 Remote Similarity NPC321874
0.6 Remote Similarity NPC227064
0.6 Remote Similarity NPC329043
0.6 Remote Similarity NPC58841
0.6 Remote Similarity NPC161423
0.5789 Remote Similarity NPC328539
0.5714 Remote Similarity NPC282593
0.5614 Remote Similarity NPC257176
0.5614 Remote Similarity NPC35734
0.5614 Remote Similarity NPC144258
0.5614 Remote Similarity NPC159577
0.5614 Remote Similarity NPC115023
0.5614 Remote Similarity NPC602429
0.5593 Remote Similarity NPC119416
0.5556 Remote Similarity NPC139397
0.5517 Remote Similarity NPC149203
0.55 Remote Similarity NPC185936
0.55 Remote Similarity NPC168027
0.5424 Remote Similarity NPC249312
0.5357 Remote Similarity NPC2634
0.5357 Remote Similarity NPC265782
0.5357 Remote Similarity NPC251929
0.5333 Remote Similarity NPC310010
0.5333 Remote Similarity NPC326627
0.5231 Remote Similarity NPC111015
0.5079 Remote Similarity NPC309603
0.5079 Remote Similarity NPC192428
0.5079 Remote Similarity NPC18509
0.5079 Remote Similarity NPC319582

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC244335 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.6038 Remote Similarity NPD4747 Phase 4
0.6 Remote Similarity NPD3666 Phase 4
0.5714 Remote Similarity NPD4221 Phase 4
0.5614 Remote Similarity NPD3618 Phase 1
0.5424 Remote Similarity NPD4693 Phase 3
0.5357 Remote Similarity NPD4691 Approved
0.5333 Remote Similarity NPD4753 Phase 2
0.5246 Remote Similarity NPD5737 Phase 4
0.5079 Remote Similarity NPD4697 Phase 2
0.5079 Remote Similarity NPD4754 Approved
0.5079 Remote Similarity NPD4755 Phase 4
0.5079 Remote Similarity NPD6672 Phase 4

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data